Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: A study of 243 scenarios
Binard A, De Bandt M, Berthelot JM, et al. Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes\: A study of 243 scenarios. Arthritis Rheum. 2007;57: 481-486.
Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: A prospective follow up study
Salvarani C, Cantini F, Niccoli L, et al. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica\: A prospective follow up study. Arthritis Rheum. 2005;53:33-38.
Anti-TNF therapy for polymyalgia rheumatica: Report of 99 cases and review of the literature
Aikawa NE, Pereira RM, Lage L, et al. Anti-TNF therapy for polymyalgia rheumatica: report of 99 cases and review of the literature. Clin Rheumatol. 2012;31:575-579.
Tocilizumab fo. The treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica
Unizony S, Arias-Urdaneta L, Miloslavsky E, et al. Tocilizumab fo. The treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica. Arthritis Care Res (Hoboken). 2012;64:1720-1729.
Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvement
Christidis D, Jain S, Das Gupta B. Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvement. BMJ Case Rep. 2011;4:1-4.
Tocilizumab for polymyalgia rheumatica: Report of two cases and review of the literature [published online ahead of print]
Macchioni P, Boiardi L, Catanoso M, et al. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature [published online ahead of print]. Semin Arthritis Rheum. 2013;43:113-118.